469 related articles for article (PubMed ID: 29349658)
1. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
[TBL] [Abstract][Full Text] [Related]
2. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.
Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q
Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410
[TBL] [Abstract][Full Text] [Related]
3. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
[TBL] [Abstract][Full Text] [Related]
4. The imbalance between regulatory and memory B cells accompanied by an increased number of circulating T-follicular helper cells in MOG-antibody-associated demyelination.
Li X; Wang L; Zhou L; ZhangBao J; Miao MZ; Lu C; Lu J; Quan C
Mult Scler Relat Disord; 2019 Nov; 36():101397. PubMed ID: 31546225
[TBL] [Abstract][Full Text] [Related]
5. Regulatory B cells in ANCA-associated vasculitis.
Wilde B; Thewissen M; Damoiseaux J; Knippenberg S; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
Ann Rheum Dis; 2013 Aug; 72(8):1416-9. PubMed ID: 23666929
[TBL] [Abstract][Full Text] [Related]
6. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
[TBL] [Abstract][Full Text] [Related]
7. [Proportion and significance of CD1d(hi)CD5⁺CD19⁺ regulatory B cell in peripheral blood of patients with neuromyelitis optica].
Yang F; Huang D; Cheng C; Wu W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):375-8. PubMed ID: 25744844
[TBL] [Abstract][Full Text] [Related]
8. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
[TBL] [Abstract][Full Text] [Related]
9. Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.
Han J; Sun L; Wang Z; Fan X; Wang L; Song YY; Zhu J; Jin T
Neurol Sci; 2017 Jul; 38(7):1205-1212. PubMed ID: 28389940
[TBL] [Abstract][Full Text] [Related]
10. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S
Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779
[TBL] [Abstract][Full Text] [Related]
11. EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.
Baek SH; Kim B; Shin JY; Choi SJ; Ahn SH; Choi YS; Kim SM; Sung JJ
J Neuroimmunol; 2021 Sep; 358():577637. PubMed ID: 34229205
[TBL] [Abstract][Full Text] [Related]
12. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
Sun Y; Huang Y; Chen WW; Jia J; Wei T
Neurol Sci; 2018 Jul; 39(7):1307-1308. PubMed ID: 29502269
[No Abstract] [Full Text] [Related]
13. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
[TBL] [Abstract][Full Text] [Related]
14. Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders.
Fan X; Jiang Y; Han J; Liu J; Wei Y; Jiang X; Jin T
Mediators Inflamm; 2016; 2016():3678152. PubMed ID: 27057097
[TBL] [Abstract][Full Text] [Related]
15. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
[TBL] [Abstract][Full Text] [Related]
16. T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Vaknin-Dembinsky A; Brill L; Kassis I; Petrou P; Ovadia H; Ben-Hur T; Abramsky O; Karussis D
Mult Scler Relat Disord; 2016 Mar; 6():28-36. PubMed ID: 27063619
[TBL] [Abstract][Full Text] [Related]
17. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
19. Peripheral CD19
Ellrichmann G; Bolz J; Peschke M; Duscha A; Hellwig K; Lee DH; Linker RA; Gold R; Haghikia A
J Neurol; 2019 Jan; 266(1):57-67. PubMed ID: 30377816
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
